Dmitry Dobrovolskiy
Lawyers
Filters
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Exchange transaction for Sabre exchangeable notes
We advised Sabre on its exchange of exchangeable senior notes
Gran Tierra Energy $100 million notes offering
The 9.5% senior notes are due 2029
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Gran Tierra Energy exchange offer and consent solicitations
The exchange offer included the issuance of new senior secured notes due 2029
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions
Equinix CHF 300 million bond offering
We advised Equinix on a Regulation S bond offering
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction
Avon $194 million tender offer
We advised Avon on its tender offer for outstanding 6.95% notes due 2043
Transfer pricing dispute for global consumer products company
We are advising a Fortune 50 company in a dispute with the IRS involving international operations